FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 357:2195-2197 November 22, 2007 Number 21 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear PubMed Citation

Cardiovascular disease is the leading cause of death in the developed world, and it is poised to become the most widespread health problem worldwide. Atherosclerosis is the major cause of cardiovascular disease. An elevated level of plasma low-density lipoprotein (LDL) cholesterol is the sine qua non for the development of atherosclerosis.¹ People with lifelong low LDL cholesterol levels are at very low risk for cardiovascular disease, yet the dramatic reduction of LDL cholesterol through the use of statin drugs over several years reduces the risk of heart attack by only 40%, largely because the disease is already established when treatment . . . [Full Text of this Article]

Source Information

From Imperial College, London.

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.